Research - News
This knowledge can aid vaccine development, treatment of infections and moderation of autoimmune disease.
Sarah Parcak, Ph.D., discusses the need to better protect artifacts at museums.
James McClintock, Ph.D., provides insight into the impact of greenhouse gases on the planet and its oceans.
Examination of a larger group of patients extends the clinical manifestations first described 11 years ago.
This research suggests a therapeutic approach to treating human heart failure.
This novel mechanism links epigenetic changes to translational control.
UAB was part of a national, multisite study that showed a drug for multiple sclerosis was effective in slowing down brain atrophy, or shrinkage.
Sensitive, specific assays are needed to ensure the safety of inter-species transplants for patients needing new organs like kidneys and hearts.
UAB-led study determines the best breathing tube for out-of-hospital cardiac arrest.
UAB will fill a gap in the stroke belt as it joins StrokeNet, a national research consortium.
“Listening-Watch” a program utilizing wearable devices and speech for two-factor authentication, thwarts potential mobile device attacks while requiring minimal effort from the user.
The grant, received from the NIH, aims to provide a better option for patients than what is already available.
An award to UAB researchers is aimed to determine effects of arsenicals and ways to treat exposure in the future.
The goal is an early warning system to block incipient seizures for patients where medications have failed.
An increased association with STI in a vaginitis screening population has been found by a UAB researcher.
This remarkable ability has clinical implications for humans.
The National Cancer Institute highlighted research from UAB that shows how the epigenetic plant-based diet in mice can prevent cancer more effectively at younger ages.
UAB research suggests protein misfolding, perhaps caused by a reduction in a regulatory protein, could be associated with Parkinson’s disease.
These newborn neurons in the dentate gyrus become less excitable after three weeks, a crucial step for mature functioning.
This discovery may lead to personalized care for congestive heart failure, also known as ischemic cardiomyopathy.
UAB's study of CBD oil for intractable epilepsy, funded by the State of Alabama under Carly's Law, shows that CBD oil reduces seizure frequency and severity in patients with treatment-resistant epilepsy.
UAB research points to a new way to lower pre-term births: teach mothers the fundamentals of oral health.
The drug targets enzymes that control the immune response and spleen macrophages.
Arts experiences may help hospitalized patients at risk of delirium.
Findings show that patients who received a blood or marrow transplant as a child may be at a higher risk of related death.
UAB is renewed for another five years in NeuroNEXT, a national clinical research program in brain disorders.
UAB was part of a groundbreaking trial that is believed to be the first time it has been proved that the risk of mild cognitive impairment and dementia can be reduced through high blood-pressure treatment.
Researchers found that prolonged oxygen supplementation adversely affected the development of memory function in preterm infants.
Two new studies will have an intriguing mix of catalysts, “tunable” chemical bonds, supercomputers and ultrafast lasers.
UAB in Antarctica has fruitful research season on Earth’s southernmost continent.